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More than 8-million people in the United States possess no kidney function. The purpose 
of this quantitative casual-comparative research study is to examine the relationship 
between ethnicity status of African American and European American patients suffering 
from end-stage renal disease, and advanced care planning and end-of-life decision-
making among patients who are 55 years of age and older. The health belief model is the 
selected explanatory framework used to examine (a) whether ethnicity status is a 
significant predictor of whether decedents had written end-of-life care instructions, (b) 
whether ethnicity status is a significant predictor of whether treatment decisions were 
made, and (c) whether ethnicity status is a predictor of whether patients 55 years of age 
and older were able to participate in these decisions during the final days of life. The 
quantitative causal-comparative research design utilized a secondary data set with 4,172 
European Americans, of whom 1,010 (24.2%) died from kidney disease, and 1,013 
African American in the sample with 289 (28.6%) who died from kidney disease. The 
logistic regression resulted in the rejection of the null hypothesis for each of the three 
research questions. The study results may be used by executive leaders to understand 
factors of patient safety, value-based care, medical technology, health care resources for 
family, and caregivers that ultimately increase the quality of life of the patient and care 
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Section 1: Foundation of the Study and Literature Review  
Introduction 
Aging patients who are 55-years-of-age or older, who have the ethnicity status 
operationalized as African American, and European American diagnosed as terminally 
ill, and who are at the end of life are highly vulnerable and need support during this 
phase. There is evidence that members of the African American population feel the end-
of-life process is stressful and many in this population are not willing to accept death 
from the advanced illness, but instead choose to seek life support and nutritional support, 
compared to and European Americans (Death, 2019). African Americans are less likely 
than and European Americans to participate in the end-of-life planning process (Rollins, 
2018). 
The ultimate goal of end-of-life planning is to support the patient and provide the 
terminally ill patient a better quality of life by designating someone to function as the 
patient’s voice at the end-of-life process. Research provides insight into the underuse of 
hospice services in the older African American population, compared to the European 
Americans, attributed to spiritual beliefs and a lack of trust in the healthcare system 
(Fraham et al., 2011). Previous research reveals reasons African American patients newly 
diagnosed with an advanced illness such as end-stage renal disease and their families 
struggle with making health care decisions prior to the time-of-death (Washington, 2016). 
The researcher has found no evidence that European American underuse hospice care 
more than African Americans (Ladin, 2018). 
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Research on the topic of leadership and end-of-life planning among elderly 
African American, and European American patients with end-stage renal disease requires 
further research to improve communication between the patient with end-stage renal 
disease, the physicians, family, and hemodialysis staff. The improved communication 
among these groups could improve participation in advance care planning and can be 
used as a guide for quality and preferences at the end of life (Eneanya, 2015). Essentially, 
improving communication and quality of care is the social change that will come from 
this research. Furthermore, findings from this research may bring social change to 
executive leaders through factors of patient safety, value-based care, medical technology, 
health care resources for family, and caregivers that ultimately increases the quality of 
life of the patient and care needs in the end-of-life period (Council, 2015). 
o improve quality in health care, there is a need to focus on value for patient 
outcomes during the end-of-life period. Efforts to respect the patient’s wishes will drive 
improvements for care and build quality performance for health care administrators and 
executive leaders in the United States (Illness, 2017). Additionally, some families are not 
willing to accept death or discuss the health care decisions of the terminally ill patient or 
family member (Grant, 2017). Advanced illness findings are based on the relationships 
between end-of-life, family engagement, and overall quality of care (Smith-Howell, 
2016). The goal of hospice utilization and end-of-life process is to support the patient, 
giving the terminally ill patient a better quality of life and designating someone as the 




For patients who are 55-years-of-age, and who have the ethnicity status of African 
American, and European American, research provides insight on the underuse of hospice 
services in the older African American population that is attributed to spiritual beliefs and 
a lack of trust in the healthcare system (Eneanya, 2015). Furthermore, research supports 
that there are racial/ethnic differences in end-of-life treatments and how minority groups 
look for sustaining life-long treatments as opposed to utilizing hospice treatments (Smith-
Howell, 2016). Education plays a significant role in how different cultures deal with 
family members who are terminally ill to participate in hospice utilization and end-of-life 
planning process (Eneanya, 2015).  
Researchers have examined the African American, European American, and 
Hispanic patients with end-stage renal disease, looking at health care decision-making for 
both ethnic/racial minority populations and nonminority populations analyzing the roles 
played by family members (Harding, 2017). In a qualitative descriptive study comparing 
African American patients to Hispanic and European Americans on end-of-life planning 
and shared decision-making of treatment options and replacement therapy (e.g., 
hemodialysis, peritoneal dialysis), Ladin (2018) found that only 13% of patients had 
discussions with their physician about end-of-life planning out of the three ethnic groups.  
The intent was to find differences between patients and families in the African 
American group as opposed to other racial/ethnicity groups with end-stage renal disease. 
An empirical study using interviews and focus groups found there was a greater need for 
improved engagement for both ethnic/racial minorities and non-minorities (Sheu, 2012). 
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End-of-life family planning assists with financial pressures and provides a caregiver or 
surrogates to make the decisions based upon what has been written by the patient. 
Essentially, the end-of-life is about the patient and quality of care for defining treatment 
options to assist with managing the process of dying (Boucher, 2016).  
The end-of-life process presents several areas of concerns and challenges that 
need to be explored to examine experiences and communication, and to understand the 
process of end-of-life planning for patients with end-stage renal disease. Some of the 
challenges and concerns are to understand why there are less engagement for improving 
engagement in the populations that appear to have less engagement with the end-of-life 
planning process in African American, Hispanic, and European American populations 
(Novelli, 2015).  
Healthcare leaders are concerned about the lack of end-of-life planning to guide 
patient-centered care in aging African American, Hispanic, and European American 
patients who are 55-years-of-age and older and suffering from end-stage renal failure 
(Wachterman et al., 2017). Furthermore, the end-of-life process is a sensitive topic that 
takes people through a range of emotions. However, death requires planning for the event 
of someone’s passing. For the terminally ill and surrounding family members, the events 
center on healthcare executives, creating clear guidelines, and documented processes for 
understanding the background and supporting the patient with preparation for end-of-life 
care.  
In some family structures, there are cultural barriers that make the end-of-life 
period challenging for both the patient and the surviving family members. In health care, 
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end-of-life planning entails appointing someone close to the patient to act as a voice if the 
patient is unable to speak (Novelli, 2015). However, to improve the quality of care, 
leaders need to focus on patient goals, preferences, and value for patient outcomes during 
the end-of-life phase to meet the requirements for patient-centered care (Death, 2019).  
According to the Joint Commission (VandeRiet, 2019) healthcare leaders are 
required to understand and know the principles of care for embracing quality principles 
of treatments for the patient exactly as written at the end of life. Essentially, healthcare 
leaders are required to have ethical relationships for positive outcomes based on the 
quality of care, patient safety, and organizational cost (VandeRiet, 2019). Furthermore, 
the Joint Commission requires healthcare leaders to honor and respect patient rights for 
culturally appropriate care that includes being informed of treatment having the right to 
refuse pain medications and being listened to with courtesy and respect (Joint, 2012). 
Advance care directives are a general document that includes written instructions from 
the patient that informs healthcare leaders of their wishes during the end-of-life planning 
process.  
Previous studies identified low rates of advance care directives contributing to the 
high cost of health care treatments at the end of life, especially among older adults who 
are African American with an advanced, terminal illness compared to the other two racial 
and ethnic groups under study, which are European American and Hispanic (Crews, 
2018). Furthermore, in this population, African Americans are less likely to participate 
with end-of-life planning or to have identified a family health care decision-maker on file 
upon hospice utilization or readmission to the hospital (Kelley, 2018).  
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Studies also support that African Americans have less family involvement prior to 
death (Washington, 2016). Efforts to respect the patient’s wishes may drive 
improvements for the high quality of care, person-and-family centered care, build quality 
performance as required for health care administrators and executive leaders in the 
United States (Illness, 2017). According to the United States Renal Data system, there are 
more than 661,000 Americans suffering from end-stage renal disease, and African 
Americans are considered 3.7 times more likely to be diagnosed, when compared to 
European American (Harding, 2017).  
However, Hispanic Americans make up 14% of the 661,000 population with end-
stage renal disease (Death, 2019). End-stage renal disease is one of the fastest-growing 
illnesses among certain populations (e.g., African Americans and Hispanics; Centers for 
Disease Control and Prevention, 2015). One in seven people is estimated to have kidney 
disease in the United States (Death, 2019). The specific problem is that more than 8 
million people in the United States possess no kidney function (Centers for Disease 
Control and Prevention, 2015).  
This study examined the relationship between ethnicity status and advance care 
planning and end-of-life decision-making among those who are 55 years of age and older 
since few of these patients among this age population have created an end-of-life plan 
(Death, 2019). Specific variables used in this study include ethnicity status and end-of-
life care instructions that will assist in addressing this ethnicity status gap. The results 
may help healthcare leaders implement practices and policies for culturally responsive 
care for elderly patients with end-stage renal disease. A plan of the next steps will give 
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the family, health care administrators, and executive leadership time to prepare advocacy 
plans for the patient. According to previous studies, the end-of-life experience should 
honor the patient’s wishes (Grant, 2017).  
Purpose of the Study 
The purpose of this quantitative casual-comparative research study was to 
examine the relationship between ethnicity status, operationalized as African American, 
Hispanic, and European American, and advance care planning and end-of-life decision-
making among those who are 55 years of age and older. Ethnicity is defined as African 
Americans, Hispanics, and European Americans (Crews, 2018).  
Advance care planning and end-of-life decision-making is defined as whether the 
decedents had written end-of-life care instructions (yes or no), whether treatment 
decisions need to be made in the final days of life (yes or no), and whether the elderly 
patients were able to participate in these decisions (e.g., medical treatment, spiritual 
wishes, resuscitate, nutrition, and family involvement). Healthcare leaders need more 
information about end-of-life planning in order to meet the needs in the patient delivery 
of care. In this study, I used multiple logistic regression to evaluate the research questions 
and intervening variables of communication between patient and doctor, and health 
beliefs of patients who may not want to participate. 
Research Questions  
Research Question 1: To what extent is ethnicity status, operationalized as 
African American, Hispanic, and European American, a significant predictor of whether 
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the decedents had written end-of-life care instructions on file among patients who are 55 
years of age and older who have end-stage renal disease? 
H10: Ethnicity status, operationalized as African American, Hispanic, and 
European American, is not a significant predictor of whether the decedents had written 
end-of-life care instructions. 
H1a: Ethnicity status, operationalized as African American, Hispanic, and 
European American, is a significant predictor of whether the decedents had written end-
of-life care instructions. 
Research Question 2: To what extent is ethnicity status, operationalized as 
African American, Hispanic, and European American, a significant predictor of whether 
documented treatment decisions in the final days of life, defined as whether decisions 
needed to be made in the final days of life among those who are 55 years of age and older 
who have end-stage renal disease? 
H20: Ethnicity status, operationalized as African American, Hispanic, and 
European American, is not a significant predictor whether documented treatment 
decisions needed to be made in the final days of life among those who are 55 years of age 
and older. 
H2a: Ethnicity status, operationalized as African American, Hispanic, and 
European American, is a significant predictor of whether treatment decisions need to be 
made in the final days of life among those who are 55 years of age and older. 
Research Question 3: To what extent is ethnicity status, operationalized as 
African American, Hispanic, and European American, a significant predictor of whether 
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the elderly patients were able to participate in treatment decisions among those who are 
55 years of age and older who have end-stage renal disease? 
H30: Ethnicity status, operationalized as African American, Hispanic, and 
European American, is not a significant predictor of a significant predictor of whether the 
elderly patients were able to participate in these decisions among those who are 55 years 
of age and older. 
H3a: Ethnicity status, operationalized as African American, Hispanic, and 
European American, is a significant predictor of a significant predictor of whether the 
elderly patients were able to participate in these decisions among those who are 55 years 
of age and older. 
Theoretical Foundation for the Study 
The health belief model was the selected framework for this doctoral study to 
evaluate personal beliefs, communication, health behaviors, knowledge, personal health 
communication, of the independent variable of ethnicity status, operationalized as 
African American, European American, and Hispanic American (Rollins, 2018). 
Additionally, this research study provided information for evaluating the dependent 
variables, and evaluating whether the decedents had documented written end-of-life care 
instructions, whether treatment decisions need to be made in the final days of life, and 
whether the elderly patients were able to participate in these decisions during the end-of-
life period. The health belief model is used to understand better communication, 
processes, and other questions that may not have answers (Jones, 2016).  
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For this study, I used the health belief model as an explanatory framework to 
explore ethnicity status and behaviors that cause less participation in end-of-life care 
instructions. Additionally, the health belief model was used as a guide for constructing 
undefined behaviors that may assist with explaining variables in this research study by 
evaluating the ethnicity status gap to help implement practices and policies for culturally 
responsive care for elderly patients with end-stage renal disease.  
The health belief model (HBM) is an explanatory communication research tool 
that may assist with the mediation of understanding the relationship of why most people 
have not thought or have had the end-of-life conversation (Becker, 1974: Champion & 
Skinner, 2008; Rosenstock, 1974). Furthermore, HBM may assist in model construction 
for healthcare leadership (e.g., physicians, managers, executives) to take action on 
writing policies on behaviors that may influence the behavior of not wanting to engage or 
participate in hospice utilization, and the end-of-life planning process. HBM explanatory 
framework may support and assist with assessing the behaviors influencing whether the 
decedents had written end-of-life care instructions or whether treatment decisions need to 
be made in the final days of life or whether the elderly patients were able to participate in 
these decisions (e.g., medical treatment, spiritual wishes, resuscitate, nutrition, and family 
involvement.).  
The health belief model was used to identify variables for performing statistical 
analysis of barriers between health care decision-making with intent to evaluate to 
determine the health beliefs that prevent African Americans from engaging in hospice 
utilization during the end-of-life period. Quantitative research is consistent and may show 
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documented measures for adults in the United States with end-stage renal disease and 
cancer diagnosis. Quantitative research also has internal documented measures of rates of 
advance care directives being on the low side, and rates of health care treatments being 
on a high at the end of life, especially among older adults who are African American 
(Hayes, 2012). Additionally, quantitative data has information on quality improvements, 
hospital readmissions, and hospice utilization that have been collected and documented 
for the cross-comparison of this study. The table below refers to research questions and 
variables used in this research study, to assist with aligning the independent variables, 
and dependent variables for those who 55 years of age and older.  
Table 1 
 
The Health Belief Model 
 The health belief model variables 
Research questions IVs DV 
To what extent is ethnicity status a 
significant predictor of whether the 
decedents had written end-of-life care 
instructions for those who are 55 years 








To what extent is ethnicity status a 
significant predictor of whether 
treatment decisions were made in the 
final days of life among those who are 





decisions need to be 
made in the final 
days of life 
To what extent is ethnicity status a 
significant predictor of whether the 
elderly patients were able to participate 
in these decisions for those who are 55 




Whether the elderly 
patients were able to 
participate in these 
decisions 
Note. IV = Independent variable; DV = Dependent variable. 
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Nature of Study 
In this doctoral research study, I used the quantitative causal-comparative 
research design to find relationships between the dependent and independent variables for 
whether the decedents had written end-of-life care instructions or whether treatment 
decisions need to be made in the final days of life or whether the elderly patients were 
able to participate in these decisions (e.g., medical treatment, spiritual wishes, resuscitate, 
nutrition, and family involvement.).  
The quantitative research design was chosen for three reasons. First, quantitative 
research is used to collect numerical data to assess whether there are statistically 
significant relationships or differences between variables (Creswell, 2018; Hair et al., 
2018; Leedy & Omrod, 2018). The purpose of this study was to examine whether 
ethnicity status predicts advance care planning and end-of-life decision-making among 
those who are 55 years of age and older. Since ethnicity is coded as a numeric variable 
and advance care planning and end-of-life decision-making are also numeric variables, 
the quantitative methodology is appropriate for this study. Second, the quantitative study 
uses a relatively large sample size, which allows for the projectability of results to the 
target population (Creswell, 2018; Hair et al., 2018; Leedy & Omrod, 2018). Third, the 
qualitative methodology would have been inappropriate for this study because it cannot 
determine statistically significant relationships between variables, and it answers “how” 
and “why” questions, while the quantitative methodology answers “what” questions. I 
conducted a linear regression to determine if there is a predictive relationship between 
variables of interest as they exist in a defined population at a single point in time or over 
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a short period of time (e.g., calendar year) (Creswell, 2018; Hair et al., 2018; Leedy & 
Omrod, 2018).  
In the current study, I examined whether ethnicity status, operationalized as 
African American, Hispanic, and European American is a significant predictor of 
whether the decedents had written end-of-life care instructions for those who are 55 years 
of age and older. Additionally, I examined a numeric variable: end-of-life planning status 
predicts another numeric variable, advance care planning, and end-of-life decision-
making among those who are 55 years of age and older.  
Therefore, casual-comparative design was appropriate for this study. The 
experimental and quasi-experimental designs were not appropriate for this study as there 
was no pre and posttest or control group. Finally, this design was appropriate because 
other studies in this field have used this design (Grant, 2017; Illness, 2017; Wachterman 
et al., 2017; Washington, 2016). 
Literature Search Strategy 
The Walden University Library of databases were used for finding peer-reviewed 
articles and journals for this research study. The databases I used were ProQuest Health, 
Medline, American Journal, American Nephrology Nurses Association, American 
Journal of Nephrology, Supportive Care for The Renal Patient, Journal of Health 
Management, Journal of Health and Organization Management, Journal of Healthcare 
Policy, Omega Journal of Death and Dying, Journal of Pain and Symptom Management, 
BMC Health Service and Research, Frontier Journal of Health Services Management, and 
Department of Health. The terms and keywords used included leadership, end-of-life 
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planning, end-stage renal disease, elderly patients with advanced illness, chronic kidney 
disease, hemodialysis, advanced care planning, and written instructions, and I obtained 
results from each of the databases used to research this study. The search was limited to 
peer-reviewed, scholarly journals and articles published between 2013 and 2019. 
Bansal (2018) provided information on patients with end-stage renal disease who 
are near the end-of-life, and challenged with not having a healthcare decision-maker on 
file, that ultimately challenged the treating nephrologist with the best patient-centered 
care. Barnett (2016) focused on the patient who is critically ill with advanced illness and 
palliative care is given for quality of treatment. Additionally, this study addressed 
advanced illnesses, components, and experiences in palliative care for decision-making 
and consistency of best treatment during the end-of-life period. Chen (2018) addressed 
cost, end-of-life, and hospice incentives for the best care. Furthermore, this article 
focuses on how the end-of-life process can drive the cost of medical care.  
Grant (2017) gave insight into cultural disparities and gaps for patients who are 
diagnosed with an advanced illness. This study also centers on end-of-life and the 
approach that families, caregivers, and healthcare professionals should engage in for 
better patient-centered care during the end-of-life process. Illness et al. (2017) addressed 
quality and improvements related to care and support to patients with an advanced illness. 
Additionally, the article is about the values of care, family engagement, and the goals for 
honoring the patient’s wishes at the end-of-life for the dignity of the patient.  
Wachterman et al. (2017) provided information on patients with advanced 
illnesses who are older and dying. This article regarded the older Americans with end-
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stage renal disease and introduced the study of the health and retirement data collection 
for best understanding the knowledge of the patient after death.  
Literature Review 
Ladin (2018) highlighted family misunderstandings, terminology for interpreting 
details of diagnoses, communication, and decision-making for the next of kin is a 
challenge that ultimately leads to barriers of communication in older adults receiving 
inadequate information during the end-of-life discussions. The participants for this study 
were recruited to take part in interviews about health literacy, end-of-life planning, and 
goals about personal health care. Additionally, the researchers shared that 31 elderly 
dialysis patients participated, and the results from this study determined that 13% of 
patients had discussions on end-of-life with their physicians. Other key findings of this 
study were communication, lack of meaningful conversations for assisting with future 
care at the end of life.  
Ephraim (2012) conducted a mixed-method study discussed African Americans 
with end-stage renal disease or an African American who has been diagnosed with a 
terminal illness (e.g., cancer, HIV, diabetes, etc.) suggesting that African Americans have 
less engagement than other racial or ethnic groups. Furthermore, additional research 
supports that European Americans account for the (81.5%) in the United States opposed 
to African Americans (8.6%), and Hispanics (6.9%) with underline use of advance care 
directives and engagement (Crews, 2018). Additionally, the study gave insight into the 
protocol of open access for the best care and focuses on African American patients and 
readiness to make decisions about kidney disease. This study explored African American 
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patients who were diagnosed with end-stage renal disease, looking at interventions, 
effectiveness, communication, and ways to promote and improve ratings of patient 
readiness, and patient-centered care. Furthermore, quantitative, and qualitative research 
was the method selected to design and test information focusing on health care decision-
making, effectiveness, communication, involvement, interventions, and financial 
assistance needed for the African American patients with end-stage renal disease.  
As a result, Ephraim’s (2012) study presented the perception of African 
Americans being less likely than European American counterparts to be prepared for end-
of-life planning and wanted to prolong medical treatments. The study also suggests 
African Americans with end-stage renal disease have trouble with indirect cost, being 
donors, and shared or informed decision-making. Recruitment of the Ephraim’s 
participants included those from an academically affiliated community-based dialysis 
center in Baltimore, MD.  
A practical guide that focused on patients diagnosed with kidney disease and was 
near the end-of-life was written by Bansal and Schell (2018). Additionally, this study will 
focus on advanced care planning and efforts to improve patient-centered care. 
Additionally, a quantitative study by Wachterman et al. (2017) focused on older 
Americans who were older than 70 years of age with end-stage renal disease. This study 
will explore end-of-life experience, assessing symptoms among older patients near the 
end of life. The study used a data source titled health and retirement study, using a 
sample of 1883 participants who passed with cancer or end-stage renal disease between 
the years of 2000 and 2010. Additionally, a study by Crews et al. (2018) centered on race 
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and ethnicity risks for patients with end-stage renal disease and dietary concerns during 
the end-of-life period. This article gave insight into the risk model accounting for death. 
The researcher used a quantitative method and a population of 1,123 non-Hispanic black 
(NHB), and non-Hispanic White (NHW). 
Phillips (2018) introduced clear points regarding chronic kidney disease and the 
patient experience regarding advanced care planning during the end-of-life within a 
hospital or community-based setting. The study used a survey to collect data for sampling 
non-probability and consecutive sampling (n = 133). Additionally, the study shared three 
different insights on patients who did not identify with having a health condition and 
those patients who felt comfortable to talk about end-of-life planning opposed to those 
who waited until their condition worsened. 
Definitions  
Elderly is defined as 55 years of age and older who have end-stage renal disease. 
Advance care planning is defined as a tool used for whether the decedents had 
written end-of-life care instructions (yes or no), whether treatment decisions need to be 
made in the final days of life (yes or no), and whether the elderly patients were able to 
participate in these decisions (e.g., medical treatment, spiritual wishes, resuscitate, 
nutrition, and family involvement; Wachterman et al., 2017). 
African American is defined as people of African American descent who are 
living in the United States and relate as Black Americans (Merriam, 1991). 
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European American is defined as people of European American descent with 
ancestry from the Northern Region of England, Ireland, Iceland, and Norway (Merriam, 
1991). 
Hispanic is defined as people who are of Hispanic American descent and are 
Latin American living in the United States relating to Spanish speaking countries (e.g., 
Mexico, Cuba, Puerto Rico, or Spain; Merriam, 1991).  
End-of-life decisions refer to a supportive care plan of action given to the 
terminally ill patient or healthy patient to document health care treatment, appoint a 
designated health care maker for making decisions in the event the patient is unable to 
speak, to extend quality of life for the best quality of care during the end-of-life period.  
End-stage renal disease is Stage 5 of chronic kidney disease that decreases the 
normal function of filtration in the body for removing waste and urine. End-stage renal 
disease is serious and is considered life-threatening. 
Leaders/leadership is defined as leaders who drive and make decisions to help 
healthcare patients in a healthcare organization. These leaders (e.g., physician-in-chief, 
chief medical administrators, department medicine managers, physician module leaders, 
chief nursing officer, chief medical officer, chief of managed care, chief legal officer, 
chief health information officer, chief executive officer) are the leaders who help shape 
healthcare policies and processes in the United States. 
Documented treatment decisions are a plan of action used when a patient has been 
diagnosed as terminally ill and near the end of life. Most importantly, documented 
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treatment decisions are used to honor the patient wishes for making healthcare decisions 
for medication, dietary needs, resuscitation, and quality of care near the end of life.  
Assumptions 
According to the United States Renal Data system, there are approximately more 
than 661,000 Americans who are 55 and older with end-stage renal disease and the 
African American population is considered 3.7 times greater for being diagnosed as 
opposed to European American (Harding, 2017). However, according to the journal of 
Chronic Kidney Disease in the United States, Hispanic Americans make up 14% of the 
661,000 individuals with end-stage renal disease (Death, 2019).  
Additionally, end-stage renal disease among the African American population 
increased by 30% (Harding, 2017), and is considered a large group in the United States 
population (Ladin, 2018). One important limitation is there is limited research on end-of-
life and family engagement. Therefore, this research will focus on the low rates of 
advance care directives and rates of health care treatments at the end of life.  
The results of this study may assist healthcare leaders to implement practices and 
policies for culturally responsive care for elderly patients with end-stage renal disease. A 
plan of the next steps will give the family, health care administrators, and executive 
leadership time to prepare advocacy plans for the patient. According to previous studies, 
the end-of-life experience should honor the patient’s wishes (Grant, 2017). The 
perception of gaps and barriers for African Americans is that they have lower rates of 
being prepared, family engagement and require financial assistance to overcome the 
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treatments of end-stage renal disease compared to Hispanic and European Americans 
(Bansal, 2017).  
This doctoral research study involves a random sampling of elderly African 
American, Hispanic, and European Americans who are 55 years of age and older with 
end-stage renal disease who reside in the United States. The Health and Retirement Study 
database contains this information (2018). Details about the sampling strategy are 
contained in the methodology section. Research on the topic of leadership and end-of-life 
planning among elderly patients with end-stage renal disease, operationalized as African 
American, Hispanic, and European American, requires further research to improve 
communication between the patient with end-stage renal disease, the physicians, family, 
and hemodialysis staff.  
The improved communication among these groups could improve participation in 
advanced care planning and can be used as a guide for quality and preferences at the end-
of-life, to better understand the gaps and barriers to each rate of advanced care directives, 
and rates of health care treatments among older adults who are operationalized as African 
American, Hispanic, and European American with end-stage renal disease is important to 
determine, and analyze if there is a lack of support at the end-of-life planning process, 
and if families struggle with working together on deciding what is best for the patient 
who has advanced illness upon hospice and hospital readmission so that patients can 
benefit before it is too late (Eneanya, 2015).  
Additionally, the HBM may have limitations for the specific ordering of the 
variables, which is a significant part of the research for testing the behaviors of the 
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independent variable advanced illness and the dependent variables healthcare decision-
making, and hospice utilization (Champion & Skinner, 2008). 
Scope and Delimitations 
It is acknowledged that there may be several delimitations for this quantitative 
study. However, the findings in this study will take further investigation that involves 
exploring leadership and elderly patients with end-stage renal disease. Studying this 
population of leadership and elderly patients diagnosed with end-stage renal disease may 
require additional data sources to determine whether the patient and family are engaged 
with the process of end-of-life planning for a better quality of care.  
Significance, Summary, and Conclusions 
The requirements of the Joint Commission 2019 require healthcare leaders to 
understand and know the principles of care for embracing quality principles of treatments 
for the patient exactly as written at the end of life. Essentially, healthcare leaders are 
required to have ethical relationships for positive outcomes based on the quality of care, 
patient safety, and organizational cost (VandeRiet, 2019). Furthermore, the Joint 
Commission requires healthcare leaders to honor and respect patient rights for culturally 
appropriate care that includes being informed of treatment, having the right to refuse pain 
medications, and being listened to with courtesy and respect (Death, 2019). According to 
GCHM (2015), leaders are responsible for improving the health of populations, 
promoting, and enhancing leadership and management policies, and practices in 
healthcare. Equally, leadership needs to be able to clearly and concisely conduct ethical 
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and professional standards for the improvement of quality care during the end-of-life 
process (GCHM, 2015).  
Healthcare leaders identified that more than 8 million people in the United States 
possess no kidney function (Centers for Disease Control and Prevention, 2015). They 
also noted that few of these patients created an end-of-life plan making it difficult to 
provide patient-centered care meeting their individual needs (Death, 2019). Previous 
studies identified low rates of advanced care directives contributing to high rates of 
health care treatments at the end-of-life, especially among older adults who are African 
American as opposed to Hispanic and European Americans (Boucher, 2016).  
The results of this study may empower the executive leadership to understand 
better-advanced care planning and end-of-life decision-making for a better quality of life, 
as it relates to racial and ethnic disparities for patients diagnosed with advanced illness to 
deliver better patient-centered care. Researchers who explored end-of-life planning 
disclosed that African Americans participate less in health care decision-making, 
compared to Hispanic and European Americans, which results in a lower quality of life 
and the healthcare staff making the end-of-life process decisions, as opposed to the 
patient or the patient’s family (Washington, 2016).  
The findings can lead to positive social change for value-based care at the end-of-
life that will drive best practices for quality of care and standardized approaches for 
person-centered care in the United States healthcare system (Illness, 2017). Additionally, 
there are several ways in which this research could contribute to the identified practice 
and professional practice in a healthcare organization and positive social change. The 
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first way leaders could use this information is implemented practices and policies for 
adapting culturally responsive care during the end-of-life. The second way would be the 
cost of care may be lower; medical errors may be avoided by respecting the patient’s 
wishes; physicians and healthcare administrators may have improved communication 
with both the patient and their family member. The third way would be that this study 
may help physicians and healthcare administrators obtain better appreciation for cultural 
differences in end-of-life planning.  
End-of-life planning is important to executive leaders for the improvement of care 
at the end-of-life and improving infrastructures (e.g., accessible care, training systems, 
and reliable resources) that will ultimately lead to reducing disparities in healthcare, 
which would be a positive effect on social change in the United States. The 
improvements in health practices noted above could result in the development of standard 
practices that are relevant to patients with advanced illnesses (Illness, 2017). 
Additionally, when someone’s loved one is diagnosed with advanced illness and is 
considered terminally ill, end-of-life care is important for implementing practices and 
policies for adapting culturally responsive care to the adult patient during the end-of-life 
period.  
The specific variables used in this study, ethnicity status and end-of-life care 
instructions, will assist in addressing the ethnicity status gap help leaders implement 
practices and policies for culturally responsive care for elderly patients with end-stage 
renal disease. A plan of the next steps may give the family, health care administrators, 
and executive leadership time to prepare advocacy plans for the patient. According to 
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recent studies, the end-of-life experience should honor the patient’s wishes (Grant, 2017). 
However, with low completion of advanced care directives, the results of this study may 
positively encourage executive leaders to create standard practices, which may change 
how patients feel about completing the advanced care directive, and potentially drive 
more patients to complete an advanced care directive, which will save time, energy, and 
cost for the family members, and the health care organization (Bansal, 2018).  
The specific positive social change may be that executive health care leaders (i.e., 
physicians, administrators, managers) ensure the patient’s wishes for end-of-life are on 
file in the patient’s health record and followed (Boucher, 2016). Furthermore, the results 
from this study may create a culture where executive leadership ensures that providers 
respect and listen to the patient's wishes during the end-of-life experience for better 
treatment and can inform leaders to create policies that will facilitate discussions for end-
of-life planning, resulting in meeting leadership requirements identified by accrediting 
and regulatory standards.  
End-of-life planning should become customary in healthcare organizations for the 
delivery of best care, patient preferences, and to shape treatment choices and plans for the 
elderly patient with an advanced illness. Phillips, MacNab, and Loewen (2018) identified 
a gap in the literature related to advanced care planning and patients who were diagnosed 
with end-stage renal disease. The research literature reported the health beliefs of the 
patients and how miscommunication occurred between the patient and healthcare 




Communication and personal beliefs are the variables derived from the literature; 
furthermore, recent research supports literature gaps related to health beliefs and the lack 
of communication, knowledge about end-of-life planning among older African American 
patients who were diagnosed with an advanced illness who lacked an advanced care 
directive on file at their selected health care organization during the end-of-life 
(Wachterman et al. (2017).  
Specifically, researchers identified that there is a gap among those who faced 
treatment at the end-of-life, but not knowing if the influencing behaviors are related to 
whether there were differences among ethnic groups on whether the decedents had 
written end-of-life care instructions, whether treatment decisions need to be made in the 
final days of life, and whether the elderly patients were able to participate in their end-of-
life decisions (Wachterman et al., 2017).  
The leaders of healthcare play an essential role in advancing new policies, 
workflows, and process changes, as it relates to a better quality of service and care. The 
implications for positive social change for healthcare administrators will include 
awareness and practical changes for creating a standard workflow for healthcare 
decision-making for clinical teams and processes to increase the completion rates of 
advanced care directives among the older population.  
Additionally, this study may contribute to the understanding that all age groups 
should have an advanced care directive completed and on file, which will help improve 
quality of life, and provide the best understanding of healthcare decision-making, and 
respecting the patient’s wishes, which may reduce errors in treatment during the end-of-
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life period. The end of life is a sensitive topic of conversation for some people who are in 
the midst of planning. However, most people do not or have not thought about having 
these respectful conversations and, as a result, go without having conversations with 
family, which results in aggressive treatments among those who are diagnosed with 
advanced illness (Grant, 2017).  
The health belief model (HBM) is an explanatory communication research tool 
that can assist with the mediation of understanding the relationship of why most people 
have not thought or have had the end-of-life conversation (Becker, 1974; Champion & 
Skinner, 2008; Rosenstock, 1974). The challenge healthcare leaders face is understanding 
how to gain the engagement of the surrounding culture in the healthcare organization to 
embrace new approaches to engage the patient and family in the conversation of end-of-
life planning, so that the information can be submitted into the patient’s healthcare 
records.  
The long-term benefits for society are the social change that will evolve through 
the end-of-life planning process in the healthcare organization with the improvement of 
quality of care, communication, right treatments, and respecting the patient's wishes 
during the end-of-life period. For health care leaders, the social change is the 
communication practices that will be used to treat the patient during the end of life, which 
allows a legal transactional approach for the physicians, medical staff, and administrators 
to follow for the best care visibly.  
The acquisition of a health care directive for the file provides executive leaders a 
legal tool to communicate the formal wishes of the patient diagnosed with advanced 
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illness in the event of incapacity during the end-of-life phase of treatment. The specific 
problem is that African Americans are less likely to participate than other racial or ethnic 
groups (e.g., Hispanic and European Americans) with end-of-life planning and 
identifying a health care decision-maker to file upon hospice utilization or readmission to 




Section 2: Research Design and Data Collection 
Introduction 
Healthcare leaders need more information about end-of-life planning in order to 
meet the needs of the patient delivery of care. The purpose of the proposed quantitative 
causal-comparative research study is to examine the population of elderly patients with 
end-stage renal disease, examining whether there is a relationship between ethnicity 
status and advanced care planning and end-of-life decision-making among those who are 
55 years of age and older. Ethnicity is defined as African Americans, Hispanics, and 
European Americans living in the United States (Crews, 2018).  
Advance care planning and end-of-life decision-making is defined as (a) whether 
the decedents had written end-of-life care instructions (yes or no), (b) whether treatment 
decisions need to be made in the final days of life (yes or no), and (c) whether the elderly 
patients were able to participate in these decisions (e.g., medical treatment, spiritual 
wishes, resuscitate, nutrition, and family involvement.). In this study, the dichotomous 
independent variables are African Americans, Hispanics, and European Americans, while 
the categorical dependent variable is advance care planning and end-of-life decision-
making. I used multiple logistic regression to evaluate the research questions and 
intervening variables of communication between patient and doctor, and health beliefs of 
patients who may not want to participate. 
Research and Design Rationale 
The secondary data set for this study came from the health and retirement study, 
which is a study of a longitudinal project that focused on the aging society and social 
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security of administration (HRS The Health and Retirement Study, 2018). This dataset 
contains a random sampling of individuals who are 55 years of age and older, have end-
stage renal disease, and reside in the United States. Specific variables and dataset for this 
study included ethnicity status and end-of-life care instructions for treatments focusing on 
end-stage renal disease patients, and the use of written life care instructions, patient able 
to participate in end-of-life care instructions, and patient able to participate in care 
decisions. 
The quantitative causal-comparative research design was used in this doctoral 
study. The purpose of this study was to examine the population of elderly patients with 
end-stage renal disease, examining whether there is a relationship between ethnicity 
status and advanced care planning and end-of-life decision-making among those who are 
55 years of age and older.  
The quantitative design was chosen for three reasons. First, the quantitative 
methodology is used when the goal is to measure variables numerically using commonly 
accepted measures of the physical world (Creswell, 2018; Hair et al., 2018; Leedy & 
Omrod, 2018). Second, the quantitative methodology is used when research questions are 
examined through the statistical examination of the data (Creswell, 2018; Hair et al., 
2018; Leedy & Omrod, 2018). Finally, the quantitative methodology is employed when 
the goal of research generalizes the findings to a larger population from which the study 
sample is derived (Creswell, 2018; Hair et al., 2018; Leedy & Omrod, 2018). Since 
ethnicity is coded as a numeric variable and advance care planning and end-of-life 
decision-making are also numeric variables, the quantitative methodology was 
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appropriate for this study. The qualitative methodology was inappropriate for this study 
because it cannot determine statistically significant relationships between variables, and it 
answers “how” and “why” questions, whereas the quantitative methodology answers 
“what” questions. 
In addition, the quantitative study uses a relatively large sample size, which 
allows for the projectability of results to the target population (Creswell, 2018; Hair et al., 
2018; Leedy & Omrod, 2018). The causal-comparative design examines the numeric 
relationship between variables of interest as they exist in a defined population at a single 
point in time or over a short period of time (e.g., calendar year; Creswell, 2018; Hair et 
al., 2018; Leedy & Omrod, 2018).  
The current study, as mentioned earlier, examined whether a numeric variable, 
end-of-life planning status, predicts another numeric variable, advance care planning and 
end-of-life decision-making among those who are 55 years of age and older. End-of-life 
planning status, advance care planning, and end-of-life decision-making are not 
manipulated variables, but variables that already exist in the defined population of those 
55 years or older.  
Therefore, the causal-comparative research design was appropriate for this study. 
The experimental and quasi-experimental designs are not appropriate for this study as 
there is no pre and posttest or control group. Finally, the causal-comparative design was 
appropriate because other studies in this field also used this design (Grant, 2017; Illness, 





The target population consists of individuals 55 years of age and older who have 
been diagnosed with end-stage renal disease in the United States. Additionally, the target 
population is limited to those who are European American, African American, and 
Hispanic. According to the United States Renal Data system, more than 661,000 
Americans age 55 and older have end-stage renal disease, and the African American 
population is 3.7 times more likely of being diagnosed as opposed to European American 
(Harding, 2017). However, Hispanic Americans makes up 14% of the population with 
end-stage renal disease (Death, 2019).  
Sampling and Sampling Procedures 
During the planning phase, the target was a sample size of 13,500 individuals 
living in 8,000 households, screened from approximately 70,000 household addresses, 
with a response rate of 80% and an eligibility rate of 19% men. In married-couple 
households, there are also a slightly larger number of women than men because, in those 
few cases where one of the couples refused to participate, men were more likely to 
refuse. HRS has a little over 2,000 African Americans, almost 1,200 Hispanics, and 9,416 
European Americans. About 63% of the samples are working for pay, some 12% are 
already retired, about 9% are disabled, and another 15% are homemakers.  
To determine the minimum sample size needed for this study, I conducted a 
power analysis using G*Power (Erdfelder, Faul, & Buchner. 1996). Sample size was 
calculated for a binary logistic regression with one binary predictor variable. Statistical 
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power was calculated with a medium effect size, a statistical power of .80, and error 
probability of .05. Based on these values, the minimum sample size to have an 80% 
chance of detecting a significant effect is 190 (see Figure 1). 
 




Instrumentation and Operationalization of Constructs 
Data was obtained from the health and retirement study (HRS), a nationally 
representative longitudinal survey of community-dwelling adults aged 51 years or older 
(HRS, 2019). Every two years until their death, HRS study participants complete a core 
interview (Juster & Suzman, 1995). Then after each participant’s death, a family member 
or some other proxy informant who is knowledgeable about the deceased participant 
complete the exit interview. This study focused on the exit interviews, and the response 
rates ranged from 85% to 92% across four study waves between 2010 and 2016 (HRS, 
2019). 
The HRS survey contained several sections. These included sections on 
demographics, physical health, and functioning, housing and mobility, family structure, 
current job, past job, work history, disability, retirement plans, net worth, and insurance. 
For this study, the sections of interest were demographics, physical health, and 
functioning, and the exit interview sections advanced care planning/decision-making and 
major illness that led to your loved one’s death. The survey took about 60 minutes to 
complete.  
Operationalization 
Across the three research questions, there was one independent variable, ethnicity, 
and three separate dependent variables related to advance care planning/decision-making. 
The first research question asked, to what extent is ethnicity status a significant predictor 
of whether the decedents had written end-of-life care instructions on file among those 55-
years of age and older who have end-stage renal disease. Ethnicity is a nominal variable 
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and operationalized as African American, European American, and Hispanic, where each 
ethnicity is assigned a numeric value. The dependent variable, whether the decedents had 
written end-of-life care instructions on file, was operationalized as a dichotomous 
variable, where 0 was no, and 1, was yes.  
The second research question asked, to what extent is ethnicity status a significant 
predictor of whether documented treatment decisions in the final days of life, defined as 
whether decisions needed to be made in the final days of life among those who are 55 
years of age and older who have end-stage renal disease. Again, ethnicity is 
operationalized as African American, European American, and Hispanic. The dependent 
variable, whether decisions needed to be made in the final days of life, where 0 is no and 
1, is yes.  
For the third research question, to what extent is ethnicity, operationalized as 
African American, Hispanic, and European American status a significant predictor of 
whether the elderly patients were able to participate in treatment decisions among those 
who are 55-years of age and older who have end-stage renal disease, ethnicity remained 
the same. The dependent variable, whether the elderly patients were able to participate in 
treatment decisions, was coded as 0 for no, and 1 for yes. All the dependent variables in 
the three research questions are dichotomous, where 0 is no and 1, is yes.  
Data Analysis Plan 
 The data analysis process consisted of three phases, the data preparation phase, 
the preliminary analysis phase, and the primary analysis phase. The data preparation 
phase consisted of the data first being input into SPSS v23 (IBM SPSS Statistics, 2019). 
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After inputting the data into SPSS, I performed frequency descriptive statistics to 
evaluate if there were any missing data or data errors. No data errors were found in data 
file.  
Since the data is obtained from a secondary source, the HRS study, it is not 
anticipated that there will many missing values or data errors, if at all. After the data is 
checked for errors and missing values, any new variables or variable recoding that needs 
to be done is completed at this point. Once this is completed, the data preparation phase is 
concluded.  
Next is the preliminary analysis phase. During this phase, the tests of parametric 
assumptions are conducted. Since the research questions are about prediction, and the 
dependent variable is dichotomous, logistic regression is performed to address the three 
research questions. The parametric assumptions to be tested for the logistic regression are 
linearity of the logit, and multicollinearity (Field, 2017, Pallant, 2016). To test for 
linearity, first, the log of the ethnicity variable is computed. Then, the log of the 
independent variables is multiplied by the independent variable value to create an 
interaction term.  
The interaction term is added to the logistic regression. If the interaction term is 
significant, then the assumption of linearity is violated (Field, 2017; Pallant, 2016). Since 
there is only one independent variable in the analysis, there is no issue with multi-
collinearity. Finally, primary analysis is conducted to address the three research 
questions. The logistic regression is conducted three times. If the p value of the logistic 
regression is less than .05, then the model as-a-whole is significant.  
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If the p value is less than .05, then the odds ratios were reviewed to determine 
which ethnic groups make a significant contribution to the model. The target population 
consists of those 55-years-of-age and older who have been diagnosed with end-stage 
renal disease in the United States. Additionally, the target population is limited to those 
who are European American African American and Hispanic. 
Threats to Validity 
Internal validity refers to whether the conclusions that are reached in the study are 
accurate. One of the threats of internal validity is maturation. It may be that the passing of 
time and the progression of their end-stage renal disease affects their ability to participate 
in their end of life care instructions. External validity refers to the generalizability of 
results. There is oversampling for African Americans and Hispanics that was 2:1 relative 
to European Americans for the HRS study. As a result, the results may not be projectable 
to the total U.S population.  
Ethical Procedures 
The data from the health and retirement study (HRS) is publicly available for 
download from the HRS web site. All that is needed is to locate the desired databased via 
the search tool on the web site. The data file contains no personally identifiable 
information in the file, so there is no concern for violations of confidentiality. The data 
will be stored in a secure, password-protected computer that is not connected to the 
internet. All protocols of the IRB are followed to ensure that there are no violations in 
ethics or IRB standards. Additionally, respondents will not be able to take the study until 
they have accepted the informed consent agreement described above. Additionally, 
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respondents under the age of 18, inmates, and pregnant patients with end-stage renal 
disease will not be included in this study.  
Summary 
The purpose of this quantitative casual-comparative research study is to examine 
the relationship between ethnicity status, operationalized as African American, Hispanic, 
and European American, and advanced care planning and end-of-life decision-making 
among those who are 55 years of age and older (Death, 2019). Data were obtained from 
the health and retirement study (HRS), a nationally representative longitudinal survey of 
community-dwelling adults aged 51 years or older.  
Every two years until their death, HRS study participants complete a core 
interview (Juster & Suzman, 1995). The data analysis process consists of three phases, 
the data preparation phase, the preliminary analysis phase, and the primary analysis 
phase. The data preparation phase consists of the data first being input into SPSS v23 




Section 3: Presentations of the Results and Findings 
Introduction 
The purpose of this quantitative causal-comparative research study is to examine 
the population of elderly patients with end-stage renal disease, examining whether there 
is a relationship between ethnicity status and advance care planning and end-of-life 
decision-making among those who are 55 years of age and older. Ethnicity is defined as 
African Americans, Hispanics, and European Americans living in the United States 
(Crews, 2018).  
There were three research questions in this study. The first research question asks, 
to what extent is ethnicity status, operationalized as African American, Hispanic, and 
European American, a significant predictor of whether the decedents had written end-of-
life care instructions on file among those who are 55 years of age and older who have 
end-stage renal disease? The second research question asks, to what extent is ethnicity 
status, operationalized as African American, Hispanic, and European American, a 
significant predictor of whether documented treatment decisions in the final days of life, 
defined as whether decisions needed to be made in the final days of life among those who 
are 55 years of age and older who have end-stage renal disease? The third research 
question asks, to what extent is ethnicity status, operationalized as African American, 
Hispanic, and European American, a significant predictor of whether the elderly patients 
were able to participate in treatment decisions among those who are 55 years of age and 
older who have end-stage renal disease? 
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This section of the dissertation consists of three subsections. Data Collection Of 
Secondary Data Set, Results, and Summary. First, in Data Collection of Secondary Data 
Set, I review the time frame for data collection, descriptive statistics of the demographic 
data, and a description of the sample. The second subsection, Results, provides the results 
of the statistical analyses. In this subsection, the three null hypotheses are tested. The first 
null hypothesis tested is that ethnicity status, operationalized as African American, 
Hispanic, and European American, is not a significant predictor of whether the decedents 
had written end-of-life care instructions. The second null hypothesis tested is that 
ethnicity status, operationalized as African American, Hispanic, and European American, 
is not a significant predictor whether documented treatment decisions needed to be made 
in the final days of life among those who are 55 years of age and older. The final null 
hypothesis tested is that ethnicity status, operationalized as African American, Hispanic, 
and European American, is not a significant predictor of a significant predictor of 
whether the elderly patients were able to participate in these decisions among those who 
are 55 years of age and older. Finally, this section concludes by summarizing the answers 
to the research and transitioning to Section 4. 
Data Collection of Secondary Data Set 
Data Collection Timeframe 
Data were obtained from the HRS, a nationally representative longitudinal survey 
of community-dwelling adults aged 55 years or older. Every 2 years until their death, 
HRS study participants completed a core interview (Juster & Suzman, 1995). Then after 
each participant’s death, a family member or some other proxy informant who was 
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knowledgeable about the deceased participant completed the exit interview. This study 
focused on the exit interviews, the response rates for which ranged from 85% to 92% 
across four study waves between 2010 and 2016 (HRS, 2019). The secondary data set I 
obtained included these four waves of data from 2010, 2012, 2014, and 2016. I 
downloaded these files and combined them into one SPSS data file. The variables used 
from the data file were ethnicity, marital status, church attendance, cause of death, having 
written end-of-life instructions, participation of the elderly patient in their health care 
decisions, and end-of-life instructions used in the final days.  
There was one discrepancy in the use of the secondary data set from what was 
planned. Before filtering the data for persons who died from kidney disease, there were 
13 Hispanics, 4,172 European American, and 1,013 African American in the sample from 
the four waves of data. After filtering the data for people who died from kidney disease, 
there were 1,010 European American and 289 African American. Therefore, Hispanics 
were excluded from the analysis. It should be noted that the selection criterion was the 
same criteria used in Wachterman et al.’s (2017) study.  
Sample Representativeness 
There was a total of 4,172 European American in the study, of whom 1,010 
(24.2%) died from kidney disease. Comparably, there were 1,013 African American in 
the sample and 289 (28.6%) who died from kidney disease. Previous research indicated 
that the African American population is diagnosed with kidney disease at a rate 3.7 times 
greater than that of European Americans (Harding, 2017). Based on this information, the 
current sample does not represent the proportional representation found in the population 
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in the United States. Therefore, the sample of the current study is not representative of 
the population.  
Results 
The purpose of this quantitative causal-comparative research study was to 
examine the population of elderly patients with end-stage renal disease, examining 
whether there is a relationship between ethnicity status and advance care planning and 
end-of-life decision-making among those who are 55 years of age and older. This section 
will present the sample of the descriptive statics, test of statistical assumptions and the 
summary of treatment of decisions. Additionally, this section provides results of ethnicity 
defined as African Americans, Hispanics, and European Americans living in the United 
States (Crews, 2018).  
Sample Descriptive Statistics 
The sample consisted of those from the health and retirement study (HRS) who 
died from kidney disease between the 2010 and 2016 waves. There were a total of 1299 
respondents in this study, of whom 77.8% were European American and 22.2% were 
African American. A majority (50.3%) of those in the study were married at the time of 
death and under half (43.1%) had written end-of-life instructions. However, over 75% of 
the respondents in the study had end-of-life instructions that were not used in the final 
days of life. Finally, over 30% of participants attended church at least once a week before 










 N % N % N % 
Marital Status       
Married 431 42.8% 222 76.8% 653 50.3% 
Separated 14 1.4% 5 1.7% 19 1.5% 
Divorced 133 13.2% 22 7.6% 155 12.0% 
Widowed 379 37.6% 33 11.4% 412 31.8% 
Never married 45 4.5% 7 2.4% 52 4.0% 
Other 6 0.6% 0 0.0% 6 0.5% 
Attend Religious Service       
More than once a week 71 7.2% 28 10.0% 99 7.8% 
Once a week 216 21.9% 71 25.3% 287 22.6% 
Two or three times a month 101 10.2% 24 8.5% 125 9.9% 
One or more times a year 178 18.0% 42 14.9% 220 17.3% 
Not at all 422 42.7% 116 42.4% 538 42.4% 
Had written end of life 
instructions 
      
Yes 195 23.8% 61 25.0% 462 43.1% 
No 624 76.2% 183 75.9% 612 56.9% 
End-of-life instructions used 
in final days 
      
Yes 498 50.1 125 43.7% 256 24.1% 
No 496 49.9 161 56.3% 807 75.9% 
 
Test of Statistical Assumptions 
There are three assumptions of the logistic regression. They are linearity of the 
logit for continuous variables, no multicollinearity, and lack of strongly influential 
outliers (Field, 2017; Tabachnick & Fidell, 2018). In this study, there is a single predictor 
variable, ethnicity, and it is categorical. It contains two groups: African American and 
European American. Because there is only one predictor variable, there is no issue with 
multicollinearity. Additionally, because the predictor variable is categorical, there is no 
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violation in the assumption of linearity of the logic for continuous variables. There is also 
no violation in the assumption of strongly influential outliers because the predictor 
variable is not continuous. Therefore, there is no violation in any of the assumptions of 
the logistic regression. 
Results of Statistical Analysis 
RQ1: To what extent is ethnicity status, operationalized as African American and 
European American, a significant predictor of whether the decedents had written end-of-
life care instructions on file among those who are 55 years of age and older who have 
end-stage renal disease? 
In the first logistic regression analysis, the outcome variable is, decedents had 
written end-of-life instructions, where 0 was no and 1 was yes. The categorical predictor 
variable was ethnicity, where 1 was European American and 2 was African American. 
The null hypothesis tested in this analysis was, ethnicity status, operationalized as 
African American and European American, is not a significant predictor of whether the 
decedents had written end-of-life care instructions. The results of the logistic regression 
indicated that the model was not statistically significant, as the p value was less than .05, 
χ2 (1) = .034, p = .85. The results indicated that the model was not able to distinguish 
between those who had written end-of-life care instructions and those who did not. 





Logistic Regression Predicting Whether Descendants had Written End-Of-Life 
Instructions 
Participation B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Had EOL Instructions -.063 .134 .034 1 .85 1.03 .79 1.33 
 
RQ2: To what extent is ethnicity status, operationalized as African American, and 
European American, a significant predictor of whether documented treatment decisions 
in the final days of life, defined as whether decisions needed to be made in the final days 
of life among those who are 55 years of age and older who have end-stage renal disease?  
 The second research question used the categorical outcome variable, whether 
documented treatment decisions were used in the final days, where 0 was no, and 1 was 
yes. The categorical predictor variable was ethnicity, where 1 was European American 
and 2 was African American. The null hypothesis tested in this analysis was, ethnicity 
status, operationalized as African American, and European American, is not a significant 
predictor whether documented treatment decisions needed to be made in the final days of 
life among those who are 55 years of age and older. Results of the logistic regression 
revealed that the model was not significant, χ2 (1) = 3.64, p = .06, indicating that the 
model was not able to distinguish between those who used documented treatment 
decisions in the final days versus those who did not. As a result, the null hypothesis was 





Logistic Regression Predicting Whether Documented Treatment Decisions Were Used in 
the Final Days 
Participation B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 EOL Instructions Used in 
Final Days 
.257 .135 3.63 1 .06 1.29 .99 1.69 
 
RQ3: To what extent is ethnicity status, operationalized as African American, 
Hispanic, and European American, a significant predictor of whether the elderly patients 
were able to participate in treatment decisions among those who are 55 years of age and 
older who have end-stage renal disease? 
The final research question contains the categorical outcome variable, elderly 
patients were able to participate in treatment decisions, where 0 was no, and 1 was yes. 
The categorical predictor variable was ethnicity, where 1 was European American and 2 
was African American. The null hypothesis under investigation is, ethnicity status, 
operationalized as African American, and European American, is not a significant 
predictor of a significant predictor of whether the elderly patients were able to participate 
in these decisions among those who are 55 years of age and older. Results of the logistic 
regression indicated that the model was not significant, χ2 (1) = 2.94, p = .09, indicating 
that the model was not able to distinguish between those elderly patients who participated 
in treatment decisions in the final days versus those who did not. As a result, the null 





Logistic Regression Predicting Whether Elderly Patients Were Able to Participate in 
Treatment Decisions 
Participation B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
 Elderly patients were able 
to participate in treatment 
decisions 
.378 .22 2.89 1 .09 1.46 .94 2.26 
 
Summary 
There were three research questions under investigation in this study related 
African American, Hispanics and European American. The results of the first research 
question indicated that the model was not statistically significant, χ2 (1) = .034, p = .85, 
indicating that the model was not able to distinguish between those who had written end-
of-life care instructions and those who did not. Therefore, the null hypothesis was not 
rejected.  
The results of the second research question, indicated that the model was not 
significant, χ2 (1) = 3.64, p = .06, indicating that the model was not able to distinguish 
between those who used documented treatment decisions in the final days versus those 
who did not. As a result, the null hypothesis was not rejected. Finally, the results of the 
third research question indicted that, that the model was not significant, χ2 (1) = 2.94, p = 
.09, indicating that the model was not able to distinguish between those elderly patients 
who participated in treatment decisions in the final days versus those who did not. As a 
result, the null hypothesis was not rejected. In the next section, the results of the three-
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research question are discussed in the context of theoretical framework and the research 
discussed in Section 2. 
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Section 4: Application to Social Professional Practice and Implications for Social Change 
Introduction 
The purpose of this section is threefold. First, I interpret the findings of the study 
in the context of the theoretical framework and the research discussed in previous 
sections. Next, I discuss the limitations. The limitations focus on issues that limit 
generalizability, validity, and reliability. Finally, this section concludes with 
recommendations for future research, as well as recommendations for future practice,  
Summary of Results 
The first research question asked, “To what extent is ethnicity status, 
operationalized as African American and European American, a significant predictor of 
whether the decedents had written end-of-life care instructions on file among those who 
are 55-years-of-age and older who have end-stage renal disease?” The results indicated 
that ethnicity status was not a significant predictor of whether someone had written end-
of-life care instructions or not. The second research question asked, “To what extent is 
ethnicity status, operationalized as African American and European American, a 
significant predictor of whether documented treatment decisions in the final days of life, 
defined as whether decisions needed to be made in the final days of life among those who 
are 55 years of age and older who have end-stage renal disease?” Results indicated that 
the model was not able to distinguish between those who used documented treatment 
decisions in the final days versus those who did not. Finally, the third research question 
asked, “To what extent is ethnicity status, operationalized as African American, , and 
European American, a significant predictor of whether the elderly patients were able to 
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participate in treatment decisions among those who are 55 years of age and older who 
have end-stage renal disease?” Results indicated that the model was not able to 
distinguish between those elderly patients who participated in treatment decisions in the 
final days versus those who did not. 
Interpretation of Findings 
Ephraim (2012) conducted a mixed-method study examining African Americans 
with end-stage renal disease or who were diagnosed with a terminal illness (e.g., cancer, 
HIV, diabetes). The results suggested that African Americans had less engagement than 
other racial or ethnic groups. Furthermore, additional research supports that more 
European Americans (81.5%) with advance care directives and engagement than African 
Americans (8.6%), and Hispanics (6.9%; Crews, 2018). 
The Ephraim (2012) presented the perception of African Americans as being less 
likely than their European American counterparts to be prepared for end-of-life planning 
and more likely to want to prolong medical treatments. Based on these findings, it was 
expected that ethnicity status would be a significant predictor of whether African 
Americans and European Americans had written end-of-life care instructions. Results of 
the study indicated that ethnicity status was not a significant predictor of whether African 
Americans and European Americans had written end-of-life care instructions. Therefore, 
this study did not support what was expected based on the Ephraim’s findings.  
It was also expected that ethnicity status would be a significant predictor of 
whether African Americans and European Americans would have documented treatment 
decisions in the final days of life. The results of the study did not support what was 
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expected, as the results indicated that ethnicity status was not a significant predictor of 
whether African Americans and European Americans would have documented treatment 
decisions in the final days of life. Finally, based on Ephraim’s (2012) study, it was 
expected that ethnicity status would be a significant predictor of whether African 
American and European American elderly patients were able to participate in treatment 
decisions. Again, the results of the current study did not support what was expected. 
Ethnicity status was not a significant predictor of whether elderly patients were able to 
participate in treatment decisions. 
A study conducted by Ladin (2018) contained participants who were recruited to 
take part in interviews about health literacy, end-of-life planning, and goals about 
personal health care. Thirty-one elderly dialysis patients participated, and the results from 
this study determined that 13% of patients had discussions on end-of-life with their 
physicians. The results highlighted that family misunderstandings, terminology for 
interpreting details of diagnoses, communication, and decision-making for the next of kin 
are challenges that ultimately lead to barriers of communication in older adults receiving 
inadequate information during the end-of-life discussions. 
In Ladin’s (2018) study, there were no noted ethnic differences in the percentage 
of patients who had discussed end-of-life with their physicians. Therefore, in the study, I 
expected that ethnicity status would not be a significant predictor of whether African 
American and European American had written end-of-life care instructions. The results 
of study supported the results of Ladin’s study, as the model was unable to distinguish 
between African Americans and European Americans who had written end-of-life care 
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instructions. This result revealed that that there were no discernable ethnic group 
differences in likelihood of having written end-of-life care instructions.  
It was also expected that ethnicity status would not be a significant predictor of 
whether African Americans and European Americans would have documented treatment 
decisions in the final days of life. A nonsignificant result would indicate that the model 
was not able to detect any no discernable ethnic group differences in likelihood of having 
documented treatment decisions in the final days of life. The results of the current study 
supported what was expected from Ladin’s (2018) study, as ethnicity status was not a 
significant predictor of whether African Americans and European Americans had 
documented treatment decisions in the final days of life. Finally, based on the results of 
Ladin’s study, it was expected that ethnicity status would not be a significant predictor of 
whether African American and European American patients were able to participate in 
treatment decisions. Again, the results of the current study supported what was expected, 
as ethnicity status was not a significant predictor of whether elderly patients were able to 
participate in treatment decisions. 
The health belief model purports that people are more likely to take preventative 
action if they believe the threat of a health risk to be serious, if they feel they are 
personally susceptible, and if there are fewer costs than benefits to engaging in it 
(Rollins, 2018). Therefore, a central aspect of the health belief model is that behavior 
change interventions are more effective if they address an individual’s specific 
perceptions about susceptibility, benefits, barriers, and self-efficacy (Jones, 2016). 
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Interventions focusing on this model may involve risk calculation and prediction, as well 
as personalized advice and education.  
The health belief model does not make any ethnicity distinctions in the belief in 
the threat of health risks to be serious, or in the perception that fewer costs than benefits 
exist in taking preventive action. Therefore, I expected that ethnicity status would not be 
a significant predictor of whether African Americans and European Americans had 
written end-of-life care instructions, and this expectation was supported in the current 
study, as ethnicity status was not a significant predictor of whether African Americans 
and European Americans had written end-of-life care instructions. I also expected that 
ethnicity status would not be a significant predictor of whether African Americans and 
European Americans would have documented treatment decisions in the final days of 
life. This was also supported in the current study, as ethnicity status was not a significant 
predictor of whether African Americans and European Americans would have 
documented treatment decisions in the final days of life. Last, based on the health belief 
model, I expected that ethnicity status would not be a significant predictor of whether 
African American and European patients were able to participate in treatment decisions. 
Again, the results of the current study supported what was expected, as ethnicity status 
was not a significant predictor of whether elderly patients were able to participate in 
treatment decisions. 
Limitations of the Study 
There were several limitations associated with this study that adversely affect the 
generalizability of the study to the larger population. First, the sample was not randomly 
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selected from the target population. As a result, the African American, European 
American, and Hispanic American populations in the sample were not proportionally 
representative of the larger population. Therefore, it is unknown whether the sample is 
biased in some way. Additionally, there were no Hispanic Americans contained in this 
sample. Therefore, no visibility exists on how this ethnic group responded to the three 
research questions. Another possible limitation of the study is that I relied on self-
reported data (Cresswell, 2018). The respondents of this study were family members who 
were caregivers of the elderly who are now deceased. For example, these caregivers 
could have suffered from selective memory, remembering only parts of experiences and 
not others. Another possible issue with self-reported data is exaggeration of events. The 
death of a loved one is a traumatic experience, and exaggeration and selective memory 
are reasonable possibilities during this time.  
Recommendations 
The first recommendation is to collect a sample that is representative of the target 
population, including being representative of the ethnic makeup of the target population. 
The sample size was acceptable, but the representativeness of sample was weak. The 
second recommendation relates to data collection. Instead of focusing on only the 
primary caregiver or family member assisting the elderly patient, it is recommended that 
at least one other person close to the elderly patient be interviewed as well. Although this 
may require additional time and financial resources, it may increase the reliability of data 
by addressing possible selective memory and exaggeration of facts. The third and final 
recommendation is that other forms of illness be considered with collecting the sample. 
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This way, distinct differences can be detected in the development of written end-of-life 
instructions across different illness types.  
Implications 
The results of this study will have implications on professional practice and 
positive social change. Details follow on the recommendations for professional practice, 
and the potential impact for positive social change at the appropriate levels. Finally, I also 
discuss the methodological implications of this study.  
Professional Practice 
There were no ethnicity differences in the proportion of respondents with written 
end-of-life planning instructions. Additionally, the percentage of African Americans and 
European Americans with written end-of-life planning instructions was relatively low. 
Therefore, one of the implications of this study on professional practice is that leaders 
and health care practitioners encourage patients to have written end-of-life instructions. 
As a result, having end-of-life instructions are helpful for the patient and provide clear 
instructions on whether the patient desires to be resuscitated, receive blood work or 
dialysis treatment, or ventilation. In this way, the wishes of the patient are ensured.  
Methodological Implications 
One of the challenges of this study was that there were not enough Hispanic 
Americans to participate in the study. Therefore, one of the methodological implications 
for this study is that if, and when, this study is replicated, that there should be a sizable 
sampling of not only Hispanic Americans, but of Asian Americans and Native Americans 
as well. This is important because it is not known if or to what degree other ethnic groups 
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have written end-of-life instructions. Without this information, there can be no 
determination of whether there should be an intervention to increase the proportion of 
people who have written end-of-life instructions in the respective ethnic groups.  
Positive Social Change 
Encouragement of all Americans to have written end of life instructions is 
important for several reasons. First, it removes the uncertainty related to the end-of-life 
care desires of patients. Second, it provides guidelines to health care professional on how 
they can effectively treat patients. Third, it documented health outcome differences 
among various ethnic and gender groups in the United States, even when controlling for 
social economic status and previous health conditions were noted. If members of these 
ethnic and gender groups who experience poorer health outcomes, possessed written end 
of life instructions, these instructions may stipulate the degree and depth of care that is 
expected from these patients and may, therefore, improve their health outcomes. For 
example, members of these poor outcome groups may be less likely to be resuscitated 
than members of other groups. Most important, having written end-of-life care 
instructions that specifically state that the patient’s desire to be resuscitated and placed on 
a ventilator are actions of care and, if done on a wider scale, may improve the health 
outcomes of patients who are at risk for poorer health and surgical outcomes, thereby 
having a positive effect on society.  
Conclusions 
Aging patients who are 55-years-of-age, and who have the ethnicity status 
operationalized as African American and European American, who are diagnosed as 
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terminally ill and are at the end-of-life are highly vulnerable and need support during this 
phase. I expected that ethnicity status would be a significant predictor of whether patients 
had or did not have written end-of-life instructions. Specifically, I expected that 
significantly fewer African Americans would report having written end of life 
instructions. However, according to the current study, half of European Americans and 
more than half of African Americans reported that they did not have written end-of-life 
instructions. So, the differences between the two groups were not sizable enough to make 
a distinction in the model.  
The results of this study benefit professional practice, future researcher, and social 
change. Leaders and health care practitioners should encourage patients to have written 
end-of-life instructions. Future studies should ensure that the sample sizes of minority 
groups are large enough to ensure that the results are projectable to the larger 
populations. Finally, if members of these ethnic and gender groups who experience 
poorer health outcomes possessed written end-of-life instructions, these instructions may 
stipulate the degree and depth of care that is expected from these patients and may, 
therefore, improve their health outcomes. There is a lot more that can be done to 
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